Skip to content

Publications & Presentations

Until a relevant regulatory agency has approved a Cara Therapeutics product for a specific disease or population, any scientific publication or presentation regarding such disease or population is not to be considered instructions on the use of the Cara Therapeutics product or clinical development candidate.

Pruritus in Dialysis Dependent Chronic Kidney Disease
Pruritus in Non-Dialysis Dependent Chronic Kidney Disease
Pruritus in Atopic Dermatitis Pruritus in Notalgia Paresthetica Kappa Opioid Receptor Agonism with Difelikefalin
Validation of Patient-Reported Outcomes